Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Kabriel Gyn Mottagning AB
AB
Active
Org 5590091459
Masthuggarvägen 10
Medical specialists activities · NACE 8622
Est. 2015
2 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
SEK 1,7M
-14% vs 2024
EBITDA margin
30.3%
-48% vs 2024
Equity ratio
37.9%
Financial strength
Net profit 2025
SEK 449K
-44% vs 2024
EBITDA — year on year
SEK millions
1M
1M
1M
0M
0M
1M
2021
0M
-100%
2022
1M
+100%
2023
1M
0%
2024
1M
0%
2025
Key figures
Annual report 2025
Revenue
SEK 1,7M
-14%
EBITDA
SEK 517K
-48%
Net profit
SEK 449K
-44%
Total assets
SEK 2,1M
-22%
Equity
SEK 797K
-24%
Employees
2
—
Company information
Legal name
Kabriel Gyn Mottagning AB
Org number
5590091459
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
30 mars 2015
Share capital
SEK 50 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-03-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget ska bedriva läkarkonsultverksamhet inom Sverige samt därmed förenlig verksamhet. Skönhetsvård.
Contact
Address
Masthuggarvägen 10
Email
selvanakabriel@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Medical specialists activities
Companies in Stockholm
All Sweden companies
Revenue
SEK millions
0M
1M
1M
2M
2M
2M
2021
2M
2022
2M
2023
2M
2024
2M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
1M
2021
0M
2022
1M
2023
1M
2024
1M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
2 378
1 588
1 813
1 986
1 705
Staff expenses
—
−1 166
−1 095
−932
−960
EBITDA
855
16
592
1 000
517
Depreciation & amort.
−0
—
—
—
—
EBIT
855
16
592
1 000
517
Net financials
−1
59
0
1
48
Profit before tax
854
593
592
1 001
565
Tax
−183
−123
−128
−206
−116
Net profit
671
470
464
795
449
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
2 680
2 280
1 616
2 703
2 100
Equity
1 119
589
1 053
1 048
797
Long-term debt
0
—
—
—
—
Short-term debt
1 042
1 691
562
1 655
1 303
Total debt
1 042
1 691
562
1 655
1 303
Financial ratios
5-year trend
EBITDA margin
30.3%
This company
15.8%
Market median
+92% vs market
2021
2025
Equity ratio
37.9%
This company
38.2%
Market median
+1% vs market
2021
2025
Return on equity
56.3%
This company
18.4%
Market median
+206% vs market
2021
2025
Net profit margin
26.3%
This company
8.1%
Market median
+225% vs market
2021
2025
Asset turnover
0.81×
This company
1.12×
Market median
+28% vs market
2021
2025
Debt / equity
1.64×
This company
0.62×
Market median
-165% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-04-01 – 2025-03-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-04-01 – 2024-03-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-04-01 – 2023-03-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-04-01 – 2022-03-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-04-01 – 2021-03-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
MK
Matta Kabriel
Deputy Board Member
2022
SK
Selvana Kabriel
Board of Directors
2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Kabriel Gyn Mottagning AB also hold positions in
0
other companies.
Person
Role here
Other companies
Matta Kabriel
Deputy Board Member
0 companies
Selvana Kabriel
Board of Directors
0 companies